APLAR 2024 Asia Pacific League of Associations for Rheumatology 26th APALR Congress 2024
The 26th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2024 will be held from August 21 to August 25, 2024, in Singapore. This congress will feature an array of internationally acclaimed speakers, regional experts, and local talents, offering cutting-edge research, scientific insights, and medical advancements through plenary sessions, concurrent workshops, and poster presentations
The 26th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2024 is designed for a diverse audience of professionals involved in the field of rheumatology. This includes:
- Rheumatologists
- Internists
- Orthopaedic surgeons
- Clinical immunologists
- Physiatrists
- Physical and occupational therapists
- Paediatricians
- Researchers from allied disciplines
The congress aims to provide a platform for these professionals to discuss and deliberate on all aspects of musculoskeletal diseases.
+ Topics:
- 2023 Japanese CPG.mp4
- Abstract session Inflammatory arthritis 2.mp4
- Abstract session Myositis Vasculitis Pain.mp4
- Advances in Management of CTD-ILD – Evidence Based Approach for Early Antifibrotic Treatment.mp4
- Allied Health Professionals.mp4
- Allosteric non-TCR contacting peptide against rheumatoid arthritis from bench to clinical translation.mp4
- APLAR 2024 L Symposium o Early intervention to elevate management goals in SLE.mp4
- APLAR Treatment Recommendation For Psoriatic Arthritic.mp4
- APLAR – EULAR symposium.mp4
- Artificial intelligence (Al) in rheumatology.mp4
- Asian Countries.mp4
- Atherosclerotic vascular disease in SLE.mp4
- Auto-inflammatory diseases in children and adults.mp4
- AxSpA.mp4
- Basic Science Update for RA Recent Insights into the Pathogenic Mechanisms in Disease Throughout Its Natural History.mp4
- Biomarkers and Data Analytics Paving the Way for Personalized Treatment with btsDMARDs in Rheumatic Conditions.mp4
- Cancer Screening in Myositis and Cancer Screening in Myositis How well are we doing.mp4
- Clinical Efficacy of Seniprutug (BOD-180), anti-TRBV9 therapy for radiographic Axial Spondyloarthritis.mp4
- Crystal Arthropathy.mp4
- Defining Progression in SSc-ILD.mp4
- Double filtration plasmapheresis reduces type 1 interferon bioavailability and inducing activity in plasma.mp4
- Early intervention in Lupus Nephritis – Asian perspective & challenges.mp4
- Fertility and sexual health in Rheumatic disease.mp4
- From clinical to molecular stratification of SSc – is precision medicine a reality.mp4
- From trials to clinical practice how do today’s therapies help patients achieve their goals.mp4
- GRAPPA Workshop @ APLAR 2024.mp4
- Health technologies and patient engagement.mp4
- How to establish APLAR SS registry and CPG.mp4
- IJRD metrics 2023.mp4
- IMAGING AND GCA-PMR SPECTRUM.mp4
- Infections and malignancy.mp4
- Infliximab from IV to SC Mainstay Therapy in Rheumatology.mp4
- Innovative Therapies in Autoimmune Diseases From Biomarker Insights to Precision Medicine.mp4
- Mental modes & thinking of Al and Gen Al.mp4
- Opening.mp4
- Osteoarthritis revisiting regional interests and new therapies.mp4
- Osteoporosis debate.mp4
- Paediatric Rheumatology- Kidneys, Blood Vessels and Skin.mp4
- Plenary session 3 Prof Debashish Danda special lectures.mp4
- Pre-conference Workshop 1.mp4
- Pre-conference Workshop 2.mp4
- Pre-conference Workshop 3.mp4
- Pre-conference Workshop Musculoskeletal Ultrasound Workshop Ankle and Foot.mp4
- Pre-conference Workshop Updates and Case Studies in LUPUS.mp4
- Raising the bar in RA and AxSpA Challenges and successes of improving lquality of care in Asia-Pacific.mp4
- Recent update in paediatric rheumatic diseases.mp4
- Reproductive Health.mp4
- Reshaping SLE care Is remission now possible for the many.mp4
- Rheumatoid Arthritis Challenges & Opportunities.mp4
- Rheumatoid Arthritis.mp4
- Rheumatology Imaging It’s values, development and future.mp4
- SLE.mp4
- Social factors affecting drug compliance in chronic diseases.mp4
- SpA.mp4
- SSR-MSR special session.mp4
- Symposium Direct Inhibition of lL-6 in Rheumatoid Arthritis Accumulated Experience and Clinical Perspectives.mp4
- Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis.mp4
- The APLAR Gout Registry Opportunities.mp4
- The Dawn of a New Era in Antiphospholipid Syndrome.mp4
- The Role of Filgotinib in the Management of Rheumatoid Arthritis.mp4
- Toward better management of vascuflfls.mp4
- Unlocking the genetic mysteries of rheumatology a journey into personalised medicine.mp4
- Validating the effectiveness of IMACS idiopathic inflammatory myopathy cancer screening guidelines in a Singapore cohort.mp4
- Vasculitis.mp4
- What is the next revolution in therapeutics in inflammatory arthritis.mp4
- Year in review.mp4